Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

133%

4 of 3 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 2

2(50.0%)

Phase 1

1(25.0%)

Phase 3

1(25.0%)

4Total

Phase 2(2)

Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT05660382Phase 3Completed

Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis

Role: lead

NCT04432376Phase 2Completed

Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis)

Role: lead

NCT03130738Phase 2Completed

Dose-Ranging Study for Miconazole Oil for Treatment of Otomycosis

Role: lead

NCT03847389Phase 1Terminated

Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis

Role: lead

All 4 trials loaded